Dermatology near Teaneck, NJ

Care Philosophy: Dr. Ritu Saini is a double board-certified dermatologist in NYC.

Care Philosophy: My goal is to provide outstanding dermatological care to patients of all ages. As all people are unique, I believe that treatment plans for patients should be individualized for optimum results. The best medicine is practiced humanely, ethically, and with expertise. I am deeply committed to providing the highest quality care and believe that does not end when the patient leaves the exam room.

Biography: Dr. Candela obtained his Medical Degree at the University of Rochester School of Medicine and Dentistry. He then went on to complete both his internship and dermatology residency at the University of Pittsburgh Medical Center. Dr. Candela has a strong interest in general medical dermatology with a focus on bullous disorders, both autoimmune and inherited. His previous clinical experience has included running an epidermolysis bullosa (EB) specialty clinic where he managed patients with simplex, junctional and dystrophic EB. Dr. Candela is an active member of the American Academy of Dermatology and has authored numerous publications and presented research at local and national conferences.

Biography: Dr. Payne is the Herbert and Florence Irving Professor and Chair of Dermatology at Columbia University Irving Medical Center. She received her BS degree in Biology from Stanford University and an MD/PhD degree in Molecular and Cellular Biology from Washington University School of Medicine, followed by dermatology residency and postdoctoral fellowship training at the University of Pennsylvania. Dr. Payne is the 2024-2025 President of the Society for Investigative Dermatology and is a member of the American Society for Clinical Investigation, NIH/NIAMS Advisory Council, and International Pemphigus and Pemphigoid Foundation Medical Advisory Council. She also serves as co-chair of the Scientific Advisory Board at Cabaletta Bio, a company she co-founded to enable the first precision cellular immunotherapies for autoimmunity to enter human clinical trials.